When Does the Cardiovascular Disease Appear in Patients With Chronic Kidney Disease?

被引:10
|
作者
Sozeri, Betul [1 ]
Mir, Sevgi [1 ]
Kara, Orhan Deniz [1 ]
Levent, Erturk [2 ]
机构
[1] Ege Univ, Fac Med, Dept Pediat Nephrol, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Pediat Cardiol, Izmir, Turkey
关键词
Cardiovascular disease; Children; Chronic kidney disease; LEFT-VENTRICULAR MASS; STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; ARTERIAL STIFFNESS; PEDIATRIC-PATIENTS; AORTIC STIFFNESS; ABDOMINAL-AORTA; YOUNG-ADULTS; CHILDREN; RISK;
D O I
10.1007/s00246-010-9710-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease is a leading cause of long-term morbidity and mortality among children with chronic kidney disease (CKD). At which stage of CKD these appear in children is unknown. This study aimed to determine the prevalence of cardiovascular disease in pediatric CKD patients and to explore the relationship of these changes and treatment methods. The study enrolled pediatric patients with stages 1-5 CKD including 20 patients receiving predialysis (PreD), 8 receiving peritoneal dialysis, and 14 receiving hemodialysis. Aortic stiffness, defined as decreased aortic strain (S) and increased pressure strain normalized by diastolic pressure (Ep*), was described. Sonography of the common carotid artery and left ventricle was performed. The mean age of the children was 13.3 +/- A 5.3 years. The patients had lower S values (0.35 +/- A 0.23) than the control subjects (0.44 +/- A 0.2) (P < 0.05) but higher Ep* (2.46 +/- A 1.31 vs. 1.32 +/- A 0.09; P < 0.05). Aortic stiffness was found in 13 patients. The PreD group had lower As levels than the dialysis group but higher levels than the control group. The patients (n = 32) had greater carotid intima-media thickness than the control subjects (0.58 +/- A 0.14 vs. 0.35 +/- A 0.12; P < 0.05). The intima-media thickness was greatest in the PreD group (P < 0.05). The patients had a higher left ventricular mass index (LVMI; 42.4 +/- A 15.6) than the control subjects (28.8 +/- A 8.47) (P < 0.05) and a larger left ventricle end diastolic diameter (LVEDD; 3.44 +/- A 0.76 vs. 2.59 +/- A 0.34; P < 0.05). Left ventricular hypertrophy was found in 32 patients. Both LVMI and LVEDD were higher in the groups receiving hemodialysis and lower in the PreD group. Increased carotid-intima media thickness and left ventricle hypertrophy appeared without hypertension in the PreD group. The indications and timing of dialysis should be reevaluated for children with CKD. In the dialysis groups, fewer cardiovascular changes were found with peritoneal dialysis than with hemodialysis. Therefore, peritoneal dialysis should be preferable to hemodialysis for children with CKD.
引用
收藏
页码:821 / 828
页数:8
相关论文
共 50 条
  • [21] Approach to Cardiovascular Disease Prevention in Patients With Chronic Kidney Disease
    Cristina Karohl
    Paolo Raggi
    Current Treatment Options in Cardiovascular Medicine, 2012, 14 (4) : 391 - 413
  • [22] Cardiovascular Imaging in Patients with Chronic Kidney Disease
    Karohl, Cristina
    Raggi, Paolo
    BLOOD PURIFICATION, 2011, 31 (1-3) : 130 - 137
  • [23] Cardiovascular Peculiarities in Patients with Chronic Kidney Disease
    Musial, Kinga
    Zwolinska, Danuta
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 112 (01) : 3 - 3
  • [24] Chronic kidney disease and cardiovascular disease
    Bondugulapati, Laxmi Narsimha Rao
    Shandilya, Saurabh
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (04) : 353 - 354
  • [25] Cardiovascular Disease in Chronic Kidney Disease
    Shoji, Tetsuo
    JOURNAL OF CARDIAC FAILURE, 2009, 15 (07) : S140 - S140
  • [26] Cardiovascular disease in chronic kidney disease
    Marx-Schuett, Katharina
    Cherney, David Z., I
    Jankowski, Joachim
    Matsushita, Kunihiro
    Nardone, Massimo
    Marx, Nikolaus
    EUROPEAN HEART JOURNAL, 2025,
  • [27] Cardiovascular disease and chronic kidney disease
    Gargiulo, Richard
    Suhail, Faten
    Lerma, Edgar V.
    DM DISEASE-A-MONTH, 2015, 61 (09): : 403 - 413
  • [28] ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials
    Wyatt, Christina M.
    Shineski, Matthew
    Chertow, Glenn M.
    Bangalore, Sripal
    KIDNEY INTERNATIONAL, 2016, 89 (06) : 1178 - 1179
  • [29] Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease
    Chernin, Gil
    Chen, Shmuel
    Ozan, Ozgu
    Liu, Mengdan
    Haberman, Dan
    Perlman, Gidon
    Ben-Yehuda, Ori
    Jonas, Michael
    AMERICAN JOURNAL OF NEPHROLOGY, 2019, 50 (06) : 465 - 472
  • [30] Cardiovascular disease in patients with chronic kidney disease: Getting to the heart of the matter
    Levin, A
    Djurdjev, O
    Barrett, B
    Burgess, E
    Carlisle, E
    Ethier, J
    Jindal, K
    Mendelssohn, D
    Tobe, S
    Singer, J
    Thompson, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (06) : 1398 - 1407